Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.52 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
| ▸ | CTRB1 | P17538 | 5/20 | 0.38 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.35 |
| ▸ | FAP | Q12884 | 1/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | XIAP | P98170 | 1/20 | 0.32 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.32 |
| ▸ | MME | P08473 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
| ▸ | CPA1 | P15085 | 1/20 | 0.31 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.31 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.31 |
| ▸ | METAP2 | P50579 | 3/20 | 0.31 |
| ▸ | METAP1 | P53582 | 3/20 | 0.31 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13598645 | 1.00 | DPP4 (0.52) | DPP4DPP8DPP7PAX8CTRB1 | |
| SCHEMBL23748421 | 1.00 | DPP4 (0.52) | DPP4DPP8DPP7PAX8CTRB1 | |
| SCHEMBL27395697 | 0.95 | DPP4 (0.48) | DPP4DPP8DPP7PAX8CTRB1 | |
| Acetic Acid SCHEMBL7446014 | 0.81 | DPP4 (0.48) | DPP4DPP8DPP7PAX8CTRB1 | |
| SCHEMBL12285707 | 0.81 | DPP4 (0.55) | DPP4DPP8DPP7FAPDPP9 | |
| SCHEMBL12522511 | 0.81 | DPP4 (0.55) | DPP4DPP8DPP7FAPDPP9 | |
| SCHEMBL14399462 | 0.81 | DPP4 (0.55) | DPP4DPP8DPP7FAPDPP9 | |
| SCHEMBL12946390 | 0.81 | DPP4 (0.55) | DPP4DPP8DPP7FAPDPP9 | |
| SCHEMBL19934697 | 0.80 | DPP4 (0.52) | DPP4DPP8DPP7PAX8CTRB1 | |
| SCHEMBL380600 | 0.80 | DPP4 (0.52) | DPP4DPP8DPP7PAX8CTRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023078021-A1 | BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-05-11 | — | — | WO | disclosed |
| EP-3901162-A1 | GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF | AbbVie Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020236817-A2 | MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | NOVARTIS AG (CH) | 2020-11-26 | — | — | WO | disclosed |
| US-9428483-B2 | Prodrug of fluorine-containing amino acid | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2016-08-30 | — | — | US | disclosed |
| US-20150306084-A1 | ADENOSINE A1 AGONISTS FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION | BAYER IP GMBH (DE) | 2015-10-29 | — | — | US | disclosed |
| US-9040566-B2 | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-05-26 | — | — | US | disclosed |
| US-20150141669-A1 | PRODRUG OF FLUORINE-CONTAINING AMINO ACID | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2015-05-21 | — | — | US | disclosed |
| US-8513381-B2 | Melanocortin analogs with antimicrobial activity | FONDAZIONE IRCCS CA' GRANDA-OSPEDALE MAGGIORE POLICLINICO (IT) | 2013-08-20 | — | — | US | disclosed |
| US-20130210797-A1 | ADENOSINE A1 AGONISTS FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-08-15 | — | — | US | disclosed |
| US-20120058983-A1 | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20120015873-A1 | MELANOCORTIN ANALOGS WITH ANTIMICROBIAL ACTIVITY | FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO (IT) | 2012-01-19 | — | — | US | disclosed |
| US-20100081786-A1 | Homogeneous Erythropoietin and Other Peptides and Proteins, Methods and Intermediates for Their Preparation | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081786-A1 | Homogeneous Erythropoietin and Other Peptides and Proteins, Methods and Intermediates for Their Preparation | EPOR, LIFR, LNPEP | DPP4 2891/4885DPP8 3824/4885DPP7 3144/4885 |
| US-20150141669-A1 | PRODRUG OF FLUORINE-CONTAINING AMINO ACID | SLC1A2, SLC1A1, SLC1A3 | DPP4 1717/4885DPP8 1393/4885DPP7 2162/4885 |
| US-20120015873-A1 | MELANOCORTIN ANALOGS WITH ANTIMICROBIAL ACTIVITY | MC4R, MC3R, MC1R | DPP4 109/4885DPP8 127/4885DPP7 78/4885 |
| US-20130210797-A1 | ADENOSINE A1 AGONISTS FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION | ADORA1, ADORA3, ADORA2A | DPP4 1079/4885DPP8 829/4885DPP7 749/4885 |
| US-20120058983-A1 | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension | ADORA1, ADORA3, ADORA2A | DPP4 1079/4885DPP8 829/4885DPP7 749/4885 |
| US-20150306084-A1 | ADENOSINE A1 AGONISTS FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION | ADORA1, ADORA3, ADORA2A | DPP4 1079/4885DPP8 829/4885DPP7 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.